CLASS III BETA-TUBULIN EXPRESSION IN NON-SMALL CELL LUNG CANCER AS A PREDICTIVE MARKER FOR PACLITAXEL

被引:0
|
作者
Ohashi, Takuya [1 ]
Yoshimasu, Tatsuya [1 ]
Oura, Shoji [1 ]
Kokawa, Yozo [1 ]
Nakamura, Rie [1 ]
Kawago, Mitsumasa [1 ]
Hirai, Yoshimitsu [1 ]
Nishiguchi, Haruka [1 ]
Matsutani, Masako [1 ]
Honda, Mariko [1 ]
Okamura, Yoshitaka [1 ]
机构
[1] Wakayama Med Univ, Dept Thorac & Cardiovasc Surg, Wakayama, Japan
关键词
Class III beta-tubulin; histoculture drug response assay; Lung cancer; predictive marker;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.01-021
引用
收藏
页码:S437 / S437
页数:1
相关论文
共 50 条
  • [41] Circulating Tumor Cell as a Predictive Marker for Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Park, C.
    Oh, H.
    Kim, M.
    Kim, B.
    Cho, H.
    Oh, I.
    Kim, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S418 - S418
  • [42] Circulating tumor cell as a predictive marker for immunotherapy in advnaced non-small cell lung cancer
    Park, Cheol-Kyu
    Yoon, Joon-Young
    Kim, Min-Suk
    Koh, Bo-Gun
    Cho, Hyun-Ju
    Oh, In-Jae
    Kim, Young-Chul
    CANCER RESEARCH, 2020, 80 (16)
  • [43] CD117 expression is a predictive marker for poor prognosis in patients with non-small cell lung cancer
    Sakabe, Tomohiko
    Azumi, Junya
    Haruki, Tomohiro
    Umekita, Yoshihisa
    Nakamura, Hiroshige
    Shiota, Goshi
    ONCOLOGY LETTERS, 2017, 13 (05) : 3703 - 3708
  • [44] Molecular marker expression in non-small cell lung cancer (NSCLC) in Humberside
    Roejkjaer, Eline
    Saleem, Azeem
    LUNG CANCER, 2024, 190
  • [45] High expression levels of class III β-tubulin in resected non-small cell lung cancer patients are predictive of improved patient survival after vinorelbine-based adjuvant chemotherapy
    Zhang, Yalei
    Yang, Haihong
    Liu, Jun
    Deng, Qiuhua
    He, Ping
    Lin, Yunen
    Jiang, Juhong
    Gu, Xia
    Mo, Mingcong
    Pan, Hui
    Xiong, Xinguo
    Qiu, Yuan
    He, Jianxing
    ONCOLOGY LETTERS, 2013, 6 (01) : 220 - 226
  • [46] Neoantigen load as a prognostic and predictive marker for stage II/III non-small cell lung cancer in Chinese patients
    Gong, Lei
    He, Ronghui
    Xu, Yanjun
    Luo, Taobo
    Jin, Kaixiu
    Yuan, Wuzhou
    Zheng, Zengguang
    Liu, Lanxuan
    Liang, Zebin
    Li, Ao
    Zheng, Zhiguo
    Li, Hui
    THORACIC CANCER, 2021, 12 (15) : 2170 - 2181
  • [47] Biomarkers in Gynecologic Cancers Class III beta-tubulin expression in uterine cancer correlates with worse outcomes
    Connor, E.
    Raker, C.
    Lomme, M.
    Dizon, D.
    Crania, C. O.
    Kawar, N.
    GYNECOLOGIC ONCOLOGY, 2015, 136 (02) : 399 - 399
  • [48] Predictive Significance of Thymidylate Synthase Expression in Non-small Cell Lung Cancer
    Kulda, Vlastimil
    Hrda, Kristyna
    Houdek, Zbynek
    Dobra, Jana Kolaja
    Vrzakova, Radana
    Svaton, Martin
    Safranek, Jarmil
    Dolezal, Jan
    Babuska, Vaclav
    Pesek, Milos
    Topolcan, Ondrej
    Pesta, Martin
    ANTICANCER RESEARCH, 2017, 37 (12) : 6953 - 6958
  • [49] Aurora B expression modulates paclitaxel response in non-small cell lung cancer
    Ahmed SK Al-Khafaji
    Michael PA Davies
    Janet M Risk
    Michael W Marcus
    Maria Koffa
    John R Gosney
    Richard J Shaw
    John K Field
    Triantafillos Liloglou
    British Journal of Cancer, 2017, 116 : 592 - 599
  • [50] Aurora B expression modulates paclitaxel response in non-small cell lung cancer
    Al-Khafaji, Ahmed S. K.
    Davies, Michael P. A.
    Risk, Janet M.
    Marcus, Michael W.
    Koffa, Maria
    Gosney, John R.
    Shaw, Richard J.
    Field, John K.
    Liloglou, Triantafillos
    BRITISH JOURNAL OF CANCER, 2017, 116 (05) : 592 - 599